Core Clinical Molecular Diagnostics Market to Hit $14.45 Bn by 2034
Core clinical molecular diagnostics applies molecular biology techniques to study diseases like cancer and infections, focusing on patient care. With the aging population increasing chronic disorders, the demand for biomarker analysis grows. Advancements in genomics and proteomics, along with a push for personalized medicine, further drive the market.
Last Updated : 21 April 2026
Category: Biotechnology
Insight Code: 5323
Format: PDF / PPT / Excel